Chronic Venous Insufficiency (CVI) Protocol

Cardiovascular HealthStrong Evidence

supplements

Primary

Supporting

Grade A

Studies

Primary Stack

Core supplements with strongest evidence

Horse Chestnut Seed ExtractA

300mg twice daily (standardized to 50mg aescin per dose)

Aescin reduces capillary permeability, improves venous tone, and decreases leg swelling and pain

↑Chronic Venous Insufficiency SignsHigh-density lipoprotein (HDL)↓Pain↑Leg Edema↓Low-density lipoprotein (LDL)

20 studies2,000 participants

Supporting Studies (2)

PMID: 23152216 - Horse chestnut for chronic venous insufficiency: Cochrane review (2012)PMID: 28241963 - Aescin for venous disorders: systematic review (2017)

Gotu Kola (Centella asiatica)A

60-180mg triterpenes daily (standardized extract)

Triterpenes strengthen connective tissue, improve microcirculation, and reduce venous hypertension

↑Chronic Venous Insufficiency Signs↑Blood Flow↑Leg Edema↑Microcirculation

15 studies1,000 participants

Supporting Studies (1)

PMID: 23191403 - Centella asiatica for chronic venous insufficiency: systematic review (2013)

Supporting Stack

Additional supplements for enhanced results

Pycnogenol (Pine Bark Extract)B

100-150mg daily

Strengthens capillary walls, reduces edema, and improves microcirculation

↑Chronic Venous Insufficiency Signs↑Leg Edema↑High-density lipoprotein (HDL)↑Low-density lipoprotein (LDL)↑Total cholesterol

10 studies500 participants

Supporting Studies (1)

PMID: 20570265 - Pycnogenol for chronic venous insufficiency: clinical study (2010)

Butcher's Broom (Ruscus aculeatus)B

150mg twice daily (standardized to ruscogenins)

Ruscogenins have venotonic effects, reducing venous stasis and improving symptoms

↑Chronic Venous Insufficiency Signs↑Leg Edema↑Subjective Well-Being

8 studies400 participants

Supporting Studies (1)

PMID: 12244879 - Ruscus aculeatus for chronic venous insufficiency: clinical study (2002)

Diosmin-Hesperidin (Micronized)A

500mg twice daily or 1000mg once daily (micronized form)

Bioflavonoids that reduce capillary permeability, improve venous tone, and reduce inflammation

↑Leg Edema Reduction↑Chronic Venous Insufficiency Symptoms↑Quality of Life in CVD↑Safety Profile

25 studies2,500 participants

Supporting Studies (1)

PMID: 26847582 - Micronized purified flavonoid fraction for CVI: meta-analysis (2016)

Grape Seed ExtractB

100-300mg daily

Proanthocyanidins strengthen vascular walls and reduce edema

8 studies400 participants

Supporting Studies (1)

PMID: 23652946 - Grape seed extract for vascular health: systematic review (2013)

How This Protocol Works

Simple Explanation

Chronic venous insufficiency (CVI) occurs when the veins in the legs don't efficiently return blood to the heart, usually due to damaged valves. Blood pools in the legs, causing symptoms like heaviness, aching, swelling, skin changes, and in severe cases, venous ulcers. CVI affects up to 40% of women and 17% of men. While compression stockings and leg elevation are foundational treatments, several well-studied plant extracts can significantly improve symptoms.

IMPORTANT: CVI should be evaluated by a healthcare provider to assess severity and rule out deep vein thrombosis. Compression therapy remains the cornerstone of treatment. These supplements can provide additional benefit.

•Horse Chestnut Seed Extract is one of the most studied natural treatments for CVI. Its active compound, aescin, reduces the permeability of tiny blood vessels (so less fluid leaks into tissues), improves venous tone, and has anti-inflammatory effects. A Cochrane review found it as effective as compression stockings for reducing leg swelling and pain.

•Gotu Kola (Centella asiatica) contains triterpenes that strengthen the connective tissue in blood vessel walls. It improves microcirculation and reduces venous pressure. Studies show it significantly reduces symptoms like heaviness, pain, and swelling, and may help prevent progression to more severe disease.

•Pycnogenol (French maritime pine bark extract) contains powerful antioxidants that strengthen capillary walls and reduce inflammation. Studies show it improves symptoms of CVI including swelling, heaviness, and discomfort. It may also help prevent the leg skin changes associated with chronic venous disease.

•Butcher's Broom contains ruscogenins that have direct venotonic effects—they cause veins to constrict, improving blood return to the heart and reducing venous pooling. European guidelines include it as a treatment option for CVI.

•Diosmin-Hesperidin (often sold as MPFF or Daflon) is widely used in Europe for venous disorders. These citrus-derived bioflavonoids improve venous tone, reduce capillary permeability, and have anti-inflammatory effects. The micronized form is better absorbed. Multiple studies show it reduces symptoms and improves quality of life.

•Grape Seed Extract contains proanthocyanidins that strengthen blood vessel walls and reduce fluid leakage into tissues. It may help reduce leg swelling and discomfort.

Expected timeline: Horse chestnut: 2-4 weeks for symptom improvement. Gotu kola: 4-8 weeks. Pycnogenol: 4-8 weeks. Diosmin: 2-4 weeks. These work best combined with compression therapy and lifestyle measures (leg elevation, exercise, avoiding prolonged standing).

Clinical Perspective

Chronic venous insufficiency involves venous valve incompetence leading to venous hypertension, capillary damage, and tissue edema. CEAP classification grades severity from C0 (no visible signs) to C6 (active ulcer). Pathophysiology includes venous reflux, obstruction, or calf muscle pump failure. Standard treatment: compression therapy (20-30 mmHg or higher), leg elevation, exercise. Venoactive drugs (phlebotropic agents) are widely used in Europe though less common in US practice.

CRITICAL: Rule out DVT in new-onset leg swelling. Compression therapy is first-line. Supplements are adjunctive. Severe CVI (skin changes, ulcers) requires specialist care.

•Horse Chestnut Seed Extract (Aesculus hippocastanum) (A-grade): Aescin inhibits hyaluronidase and elastase (reduces vascular wall degradation), decreases capillary permeability, has anti-inflammatory and venotonic effects. Cochrane review (17 RCTs): significant reduction in leg pain, edema, and pruritus vs placebo; comparable to compression stockings (PMID: 23152216). Systematic review confirms efficacy and safety (PMID: 28241963). 300mg BID standardized to 50mg aescin/dose. Rare GI upset; contraindicated with anticoagulants.

•Gotu Kola (Centella asiatica) (A-grade): Triterpenic compounds (asiaticoside, asiatic acid, madecassic acid) stimulate collagen synthesis, improve capillary permeability, and reduce venous hypertension. Total triterpenic fraction of Centella asiatica (TTFCA) most studied. Systematic review: improves microcirculatory parameters and clinical symptoms (PMID: 23191403). 60-180mg triterpenes daily (corresponds to 60-120mg TTFCA). Well-tolerated.

•Pycnogenol (B-grade): Oligomeric proanthocyanidins bind to collagen and elastin, reducing degradation. Inhibits matrix metalloproteinases. Clinical study: improved symptoms (heaviness, pain, edema), reduced limb volume (PMID: 20570265). Also studied for prevention of flight-related edema. 100-150mg daily.

•Butcher's Broom (Ruscus aculeatus) (B-grade): Ruscogenins are α1-adrenergic agonists with venoconstrictive effects; also inhibit elastase. Clinical study: improved venous symptoms in combination with hesperidin and ascorbic acid (PMID: 12244879). ESCOP and German Commission E approved for CVI. 150mg BID standardized extract.

•Diosmin-Hesperidin / MPFF (Micronized Purified Flavonoid Fraction) (A-grade): Diosmin (90%) and hesperidin (10%), micronized for bioavailability. Increases venous tone, reduces capillary hyperpermeability, has anti-inflammatory effects. Meta-analysis: significant improvement in leg symptoms (pain, heaviness, feeling of swelling) and quality of life (PMID: 26847582). Also accelerates venous ulcer healing. 500mg BID or 1000mg daily. Daflon, Detralex are brand names.

•Grape Seed Extract (B-grade): Oligomeric proanthocyanidins (OPCs) bind vascular wall proteins, inhibit enzymes degrading connective tissue. Systematic review: supports vascular health, reduces edema (PMID: 23652946). 100-300mg daily. Well-tolerated.

Biomarker targets: Clinical symptom scores (VCSS, CIVIQ), ankle circumference/leg volume, quality of life measures, ulcer healing rate if applicable, duplex ultrasound for venous reflux assessment.

Protocol notes: Compression therapy (stockings, wraps) is cornerstone—20-30 mmHg for mild CVI, 30-40 mmHg for moderate-severe. Leg elevation above heart level when possible. Regular walking/calf exercises activate muscle pump. Avoid prolonged standing/sitting. Weight loss if overweight. Skin care to prevent ulcers. Sclerotherapy or endovenous ablation for symptomatic varicose veins. Wound care for venous ulcers (compression essential for healing). Intermittent pneumatic compression for severe edema. Assess for arterial disease before applying high compression. Screen for underlying causes (previous DVT, pelvic mass). Venoactive drugs widely used in Europe; less common in US guidelines but evidence supports benefit.

View All Protocols